Raymond James Financial’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$801M Sell
6,236,773
-348,741
-5% -$40.8M 0.22% 78
2026
Q1
$792M Sell
6,585,514
-343,142
-5% -$39.6M 0.24% 70
2025
Q4
$729M Sell
6,928,656
-78,797
-1% -$7.4M 0.23% 80
2025
Q3
$588M Sell
7,007,453
-629,712
-8% -$51.9M 0.19% 93
2025
Q2
$605M Sell
7,637,165
-8,003,727
-51% -$636M 0.21% 87
2025
Q1
$1.4B Sell
15,640,892
-51,440
-0.3% -$4.8M 0.53% 26
2024
Q4
$1.56B Buy
+15,692,332
New +$1.62B 0.58% 24

Other funds holding MRK

Raymond James Financial's MRK Position: Q2 2026 in Review

Raymond James Financial reduced its Merck (MRK) stake by 5.3% in Q2 2026, selling an estimated $40.8M and leaving 6,236,773 shares worth $801M. The position accounts for 0.22% of the portfolio, ranked #78.

Raymond James Financial first reported a position in MRK in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.56B in Q4 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Raymond James Financial held 6,236,773 shares of Merck worth $801M as of Q2 2026.
  • Raymond James Financial sold 348,741 Merck shares in Q2 2026, an estimated $40.8M.
  • Merck made up 0.22% of Raymond James Financial's portfolio in Q2 2026, its #78 holding.
  • Raymond James Financial first reported a position in Merck in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Merck position peaked at $1.56B in Q4 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.